LREN3:BMFBOVESPALojas Renner S.A. Analysis
Data as of 2026-06-02 - not real-time
ARS 4,437.50
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
LREN3 is trading at 4,437.5, comfortably above its 20‑day (4,289.75), 50‑day (4,329.25) and 200‑day (4,191.24) simple moving averages, signaling short‑term strength. Technical momentum is reinforced by a bullish MACD (histogram +32.66) and a neutral‑to‑bullish RSI at 54, while daily volume is on an upward trend, suggesting growing trader interest.
Fundamentally, the retailer delivers solid profitability with a 9.4% net margin, 14.5% ROE and a healthy 62% gross margin, yet revenue growth is modest at 3.3% YoY. The stock appears **undervalued** on a price‑to‑book basis (0.37×) and carries a manageable debt‑to‑equity ratio (~28%), though net debt remains positive.
Risk factors are notable: 30‑day volatility is high at 54%, beta exceeds 1.0, and the consumer‑cyclical sector is sensitive to economic swings in Brazil and neighboring markets. Currency exposure (ARS) and emerging‑market geographic concentration add further upside‑down risk, while the absence of a dividend eliminates income stability.
Fundamentally, the retailer delivers solid profitability with a 9.4% net margin, 14.5% ROE and a healthy 62% gross margin, yet revenue growth is modest at 3.3% YoY. The stock appears **undervalued** on a price‑to‑book basis (0.37×) and carries a manageable debt‑to‑equity ratio (~28%), though net debt remains positive.
Risk factors are notable: 30‑day volatility is high at 54%, beta exceeds 1.0, and the consumer‑cyclical sector is sensitive to economic swings in Brazil and neighboring markets. Currency exposure (ARS) and emerging‑market geographic concentration add further upside‑down risk, while the absence of a dividend eliminates income stability.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price above key moving averages
- Bullish MACD and rising volume
- Proximity to resistance at 4,560
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Undervalued price‑to‑book ratio
- Strong ROE and profit margins
- Potential recovery in consumer‑cyclical spending
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- Sustainable earnings and cash flow generation
- Debt level manageable but requires monitoring
- Exposure to emerging‑market macro risks
Key Metrics & Analysis
Financial Health
Revenue Growth3.30%
Profit Margin9.37%
ROE14.48%
ROA6.42%
Debt/Equity27.93
P/B Ratio0.4
Op. Cash FlowARS3.0B
Free Cash FlowARS1.7B
Technical Analysis
TrendNeutral
RSI54.3
SupportARS 3,892.50
ResistanceARS 4,560.00
MA 20ARS 4,289.75
MA 50ARS 4,329.25
MA 200ARS 4,191.24
MACDBullish
VolumeIncreasing
Fear & Greed Index92.63
Valuation
Fair ValueARS 25.29
GradeUndervalued
TypeBlend
Risk Assessment
Beta1.11
Volatility54.39%
Sector RiskHigh
Reg. RiskMedium
Geo RiskHigh
Currency RiskHigh
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.